Neumora Therapeutics, Inc. Common Stock (NMRA)
$10.32 -$0.40 (-3.83%) 4:38 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$1.66B -
Day's Range
$10.20 - $10.80 -
Volume
930,917 -
52 Week Low / High
$8.33 - $21.00 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
NMRA's Dividend
Analyists Ranking
- 5
- Strong Buy
- 3
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $20.83
- Target Price
Company News
-
Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders — Aug 14th, 2024
Neumora Therapeutics, Inc. Roundtable discussion to take place on Thursday, September 12 at 8:00 a.m. ET WATERTOWN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of se...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$